2 completed, 1 enrolling by invitation. .
Follow ASH Research Collaborative: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COVID19 OutcomeS in Myeloma and the Impact of VaCcines Patient Reported Outcomes - Multiple Myeloma | Completed | ASH Research Collaborative | 201 | 2024-01-23 | 2026-05-18 | |
| COVID-19 Vaccine Response in Sickle Cell Disease COVID-19 Vaccine - Sickle Cell Disease, COVID-19 | Completed | ASH Research Collaborative | 59 | 2021-12-01 | 2025-02-14 | |
| ASH Research Collaborative Data Hub Sickle Cell Disease, Multiple Myeloma | Enrolling by invitation | ASH Research Collaborative | 100000 | 2020-04-29 | 2024-06-17 |
Anemia, Sickle Cell (2) · COVID-19 (2) · Multiple Myeloma (2) · Neoplasms, Plasma Cell (2)
COVID-19 Vaccines (1) · Patient Reported Outcome Measures (1)
United States (3)
Charles Abrams, MD (1) · Saad Usmani, MD,MBA,FACP (1) · Sophie Lanzkron, MD (1) · William Wood, MD, MPH (1)